CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 99 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $93,520 | -4.8% | 5,867 | +0.4% | 0.00% | -20.0% |
Q4 2023 | $98,271 | +43.8% | 5,846 | 0.0% | 0.01% | +25.0% |
Q3 2023 | $68,340 | -7.8% | 5,846 | +6.0% | 0.00% | 0.0% |
Q2 2023 | $74,095 | -18.9% | 5,513 | 0.0% | 0.00% | -20.0% |
Q1 2023 | $91,406 | -21.9% | 5,513 | -12.4% | 0.01% | 0.0% |
Q4 2022 | $117,068 | +45.0% | 6,294 | 0.0% | 0.01% | +25.0% |
Q3 2022 | $80,752 | +83.0% | 6,294 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $44,121 | -15.4% | 6,294 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $52,177 | -67.3% | 6,294 | -73.3% | 0.00% | 0.0% |
Q4 2021 | $159,610 | +14.0% | 23,576 | -10.7% | 0.00% | 0.0% |
Q3 2021 | $139,957 | +9.2% | 26,407 | +18.4% | 0.00% | 0.0% |
Q2 2021 | $128,214 | -8.3% | 22,298 | -26.5% | 0.00% | 0.0% |
Q1 2021 | $139,766 | +52.0% | 30,318 | +10.1% | 0.00% | +100.0% |
Q4 2020 | $91,937 | +10.7% | 27,526 | -1.6% | 0.00% | 0.0% |
Q3 2020 | $83,053 | -42.2% | 27,964 | -10.0% | 0.00% | -66.7% |
Q2 2020 | $143,627 | +85.3% | 31,088 | +54.4% | 0.00% | +50.0% |
Q1 2020 | $77,497 | +28.8% | 20,129 | +25.4% | 0.00% | +100.0% |
Q4 2019 | $60,188 | -68.3% | 16,050 | -55.1% | 0.00% | -66.7% |
Q3 2019 | $189,902 | +74.9% | 35,763 | +26.5% | 0.00% | +50.0% |
Q2 2019 | $108,599 | -24.7% | 28,281 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $144,233 | +175.6% | 28,281 | +3.8% | 0.00% | +200.0% |
Q4 2018 | $52,326 | -49.2% | 27,253 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $103,016 | -99.9% | 27,253 | 0.0% | 0.00% | +100.0% |
Q2 2018 | $85,030,000 | +74.7% | 27,253 | +33.8% | 0.00% | 0.0% |
Q1 2018 | $48,680,000 | +55854.0% | 20,368 | -8.3% | 0.00% | 0.0% |
Q4 2017 | $87,000 | -36.0% | 22,204 | -60.1% | 0.00% | 0.0% |
Q4 2015 | $136,000 | -4.2% | 55,663 | +17.3% | 0.00% | 0.0% |
Q3 2015 | $142,000 | -39.6% | 47,445 | -16.6% | 0.00% | -50.0% |
Q2 2015 | $235,000 | – | 56,871 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |